“There are four ways,” he told The Daily Beast. “One, it peters out with the weather. Two, everybody gets infected, so it’s got no new places to go… so it ends—but that’s a pretty horrible ending. Three is a vaccine, which is about a year away. Fourth way is the most likely: We’re going to have a few drugs, within a few weeks to a few months, that prevent people from getting infected—like PrEP for HIV—and for treatment.”…
Haseltine said the likelihood is that at least one treatment option will be available through the public health system within weeks or months, and might even prevent the virus.
Dr. Klausner named two specific antiviral agents that look promising, including remdesivir and actemra, the latter of which he called “essentially a synthetic antibody” that is “currently being used and recommended for use in China” to treat the new coronavirus. It has been jointly manufactured by Roche and Chugai Pharmaceutical for use as an anti-inflammatory drug for rheumatoid arthritis.
Meanwhile, remdesivir, which was created by Gilead Sciences, has been reported as the most promising possible treatment for the virus because it is a “broad spectrum” drug that has shown effectiveness against various viral targets in lab testing.